Luca Issi
Stock Analyst at RBC Capital
(3.91)
# 645
Out of 5,090 analysts
219
Total ratings
50.76%
Success rate
9.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Sector Perform | $28 → $25 | $27.70 | -9.75% | 18 | Nov 21, 2025 | |
| AGIO Agios Pharmaceuticals | Downgrades: Sector Perform | $57 → $28 | $27.73 | +0.97% | 1 | Nov 20, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $45 → $52 | $61.44 | -15.36% | 10 | Nov 19, 2025 | |
| KRRO Korro Bio | Downgrades: Sector Perform | $85 → $8 | $7.02 | +13.96% | 8 | Nov 13, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Sector Perform | $42 → $50 | $56.88 | -12.10% | 15 | Nov 11, 2025 | |
| RGNX REGENXBIO | Maintains: Outperform | $17 → $19 | $13.16 | +44.38% | 11 | Nov 7, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Sector Perform | $14 → $9 | $9.61 | -6.35% | 7 | Nov 7, 2025 | |
| DYN Dyne Therapeutics | Maintains: Outperform | $23 → $30 | $20.28 | +47.93% | 4 | Nov 6, 2025 | |
| QURE uniQure | Maintains: Outperform | $65 → $45 | $21.33 | +110.97% | 7 | Nov 4, 2025 | |
| ARGX argenx SE | Maintains: Outperform | $850 → $860 | $901.17 | -4.57% | 2 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $82 | $81.68 | +0.39% | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $7 | $8.90 | -21.35% | 2 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $61 → $72 | $71.63 | +0.52% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $435 → $500 | $458.12 | +9.14% | 28 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $210 → $230 | $205.44 | +11.95% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $4.26 | -6.10% | 8 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.43 | +599.30% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $23.63 | -23.83% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $9.35 | +113.90% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.50 | +303.31% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $12.58 | +35.14% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $8.65 | +50.29% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $10.70 | +227.10% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $27.09 | -4.02% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $53.40 | +31.09% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $38.46 | +48.21% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $2.42 | +65.29% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $36.38 | +111.65% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $15 | $7.49 | +100.27% | 5 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.90 | +636.84% | 5 | Aug 7, 2024 |
Moderna
Nov 21, 2025
Maintains: Sector Perform
Price Target: $28 → $25
Current: $27.70
Upside: -9.75%
Agios Pharmaceuticals
Nov 20, 2025
Downgrades: Sector Perform
Price Target: $57 → $28
Current: $27.73
Upside: +0.97%
Arrowhead Pharmaceuticals
Nov 19, 2025
Maintains: Outperform
Price Target: $45 → $52
Current: $61.44
Upside: -15.36%
Korro Bio
Nov 13, 2025
Downgrades: Sector Perform
Price Target: $85 → $8
Current: $7.02
Upside: +13.96%
CRISPR Therapeutics AG
Nov 11, 2025
Maintains: Sector Perform
Price Target: $42 → $50
Current: $56.88
Upside: -12.10%
REGENXBIO
Nov 7, 2025
Maintains: Outperform
Price Target: $17 → $19
Current: $13.16
Upside: +44.38%
Intellia Therapeutics
Nov 7, 2025
Maintains: Sector Perform
Price Target: $14 → $9
Current: $9.61
Upside: -6.35%
Dyne Therapeutics
Nov 6, 2025
Maintains: Outperform
Price Target: $23 → $30
Current: $20.28
Upside: +47.93%
uniQure
Nov 4, 2025
Maintains: Outperform
Price Target: $65 → $45
Current: $21.33
Upside: +110.97%
argenx SE
Oct 31, 2025
Maintains: Outperform
Price Target: $850 → $860
Current: $901.17
Upside: -4.57%
Oct 30, 2025
Maintains: Outperform
Price Target: $80 → $82
Current: $81.68
Upside: +0.39%
Oct 30, 2025
Maintains: Sector Perform
Price Target: $5 → $7
Current: $8.90
Upside: -21.35%
Oct 28, 2025
Downgrades: Sector Perform
Price Target: $61 → $72
Current: $71.63
Upside: +0.52%
Sep 19, 2025
Maintains: Outperform
Price Target: $435 → $500
Current: $458.12
Upside: +9.14%
Aug 8, 2025
Maintains: Outperform
Price Target: $210 → $230
Current: $205.44
Upside: +11.95%
May 15, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $4.26
Upside: -6.10%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.43
Upside: +599.30%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $23.63
Upside: -23.83%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $9.35
Upside: +113.90%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.50
Upside: +303.31%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $12.58
Upside: +35.14%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $8.65
Upside: +50.29%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $10.70
Upside: +227.10%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $27.09
Upside: -4.02%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $53.40
Upside: +31.09%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $38.46
Upside: +48.21%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.42
Upside: +65.29%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $36.38
Upside: +111.65%
Oct 21, 2024
Maintains: Sector Perform
Price Target: $7 → $15
Current: $7.49
Upside: +100.27%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.90
Upside: +636.84%